Cognitive Impairment Clinical Trials in New York, New York

4 studies are recruiting for cognitive impairment in New York, New York right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

1. Early Age-Related Hearing Loss Investigation (EARHLI)

   Early Age-Related Hearing Loss Investigation (EARHLI) is a single site study that will randomize late middle age adults to either a hearing intervention (including hearing aids) or a health education intervention. Participants will be followed for 1 year. This study will provide information on redu…

   Stage

   Not phased

   Ages

   55 to 75

   Site

   Columbia University Medical Center, New York, New York

   Run by

   Columbia University

   See if you can join NCT06174038 on ClinicalTrials.gov

2. Improving Self-Care of Caregivers of Adults in Homecare With Heart Failure and Cognitive Impairment

   This RCT design will enroll 256 informal caregivers (spouse/partner or child) of HHC patients with HF/CI and 60 patients with HF and mild to moderate CI (60 dyads). After collecting baseline data, we will block randomize the caregivers 1:1 to the ViCCY intervention or comparator group, stratifying …

   Stage

   Not phased

   Ages

   18 to 101

   Site

   VNS Health, New York, New York

   Run by

   Visiting Nurse Service of New York

   See if you can join NCT07220798 on ClinicalTrials.gov

3. Evaluating the Efficacy of the Pain Identification and Communication Toolkit

   This study will evaluate the Pain Identification and Communication Toolkit (PICT), a multicomponent intervention for caregivers of people with Alzheimer's disease and related dementias (ADRD). PICT provides training in observational pain assessment and coaching in effective pain communication techn…

   Stage

   Not phased

   Ages

   21 and older

   Site

   Weill Cornell Medicine, New York, New York

   Run by

   Weill Medical College of Cornell University

   See if you can join NCT06168604 on ClinicalTrials.gov

4. Study of ALTO-101 in Patients With Schizophrenia

   This is a Phase 2, double-blind, placebo-controlled, two-way crossover study to compare the efficacy of ALTO-101T versus placebo in change in electroencephalogram (EEG) cognitive processing markers and measures of cognition. Additional goals are to assess pharmacokinetic (PK), safety, and tolerabil…

   Stage

   Phase 2

   Ages

   21 to 55

   Site

   Site 5108, New York, New York

   Locations

   14 in total

   Run by

   Alto Neuroscience

   See if you can join NCT06502964 on ClinicalTrials.gov